OPR - Delayed Quote • USD HIMS Jul 2025 25.000 call (HIMS250718C00025000) Follow 1.0500 0.0000 (0.00%) As of April 25 at 10:10 AM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for HIMS250718C00025000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: HIMS Jefferies downgrades Hims & Hers Health on growth concerns Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024 Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member Nvidia's valuation forecasts aren't 'justified': Portfolio manager Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024 Hims & Hers Health, Unity Software: After-Hours Movers Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
